Zepon PR Tablet is a combination medication containing Clonazepam 0.5 mg and Escitalopram Oxalate 10 mg, formulated for the management of anxiety disorders, panic attacks, and depressive symptoms. Clonazepam, a benzodiazepine, exerts its therapeutic effect by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby producing anxiolytic, anticonvulsant, and muscle-relaxant properties. Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels in the brain by inhibiting its reuptake into presynaptic neurons, contributing to improved mood and reduced anxiety. The combination of these agents provides a synergistic effect, addressing both the immediate relief of anxiety symptoms through Clonazepam and the long-term management of depression and anxiety via Escitalopram. Zepon PR Tablet is indicated for patients requiring both rapid symptom control and sustained antidepressant therapy. It should be used under strict medical supervision due to potential side effects such as sedation, dizziness, gastrointestinal disturbances, and the risk of dependence associated with benzodiazepines. Caution is advised in patients with a history of substance abuse, liver or kidney impairment, and during pregnancy or lactation. Regular monitoring and adherence to prescribed dosages are essential to ensure safety and therapeutic efficacy.